Skip to content

A study of treatment of allergic disorders with MSC-CM

A Study of Treatment of Allergic Disorders (e.g., Pollinosis or Atopic Dermatitis) with Human Mesenchymal Stem Cell Conditioned Medium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051230176
Enrollment
Unknown
Registered
2024-01-26
Start date
2024-01-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Disorder (such as Pollinosis or Atopic Dermatitis)

Interventions

None listed

Sponsors

Nagamine Yukiko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Individuals who have not experienced satisfactory results in the treatment of allergic diseases with standard therapy. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and have been deemed suitable for allergic disease treatment with conditioned medium by a physician. The patient selection criteria are as follows: Patients meeting the following criteria will be considered eligible: Individuals aged 18 and above. Individuals with normal decision-making capacity. Individuals who have been provided with the informed consent document regarding this treatment, received sufficient explanation, and can provide voluntary written consent. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Individuals meeting any of the following conditions will be excluded from the study: 1. Users of narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

MeasureTime frame
Assessment of self-reported symptoms corresponding to types ofallergic conditions

Contacts

Public ContactYukiko Nagamine

Nagamine Medical Clinic Ginza

ginza@nagamineclinic.com+81-3-6280-6546

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026